Functions of SETD7 during development, homeostasis and cancer

Soshnikova, Natalia

doi:10.21037/sci.2019.06.10

Cited by 3 publications

(1 citation statement)

References 24 publications

(29 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In previous studies, SETD7 was shown to be highly expressed in chondrocytes at 20 compared with 1% O 2 ( 13 , 49 ). The present study demonstrated that at 1% O 2 , decreased SETD7 expression leads to inhibition of Hippo signaling and an increase in YAP entering the nucleus.…”

Section: Discussionmentioning

confidence: 85%

SETD7 regulates chondrocyte differentiation and glycolysis via the Hippo signaling pathway and HIF‑1α

Ning

Wang

et al. 2021

Int J Mol Med

View full text Add to dashboard Cite

Chondrocytes are well adapted to hypoxia and produce more functional extracellular matrix in low oxygen environments in vitro . In our previous study, methyltransferase SET domain containing (SETD)7 regulated chondrocyte activity in hypoxic conditions. However, the precise association between SETD7 and chondrocyte differentiation under low oxygen partial pressure remains unclear. The association between SETD7 and chondrocyte differentiation was studied by silencing SETD7 in chondrocytes in vitro . The results showed that the silencing of SETD7 in ATDC5 cells inhibited the Hippo signaling pathway, decreased Yes-associated protein (YAP) phosphorylation and increased the levels of YAP and hypoxia inducible factor-1α (HIF-1α) in the nucleus. YAP combined with HIF-1α to form a complex that promoted the expression of genes involved in chondrogenic differentiation and the glycolytic pathway. Thus, SETD7 inhibited chondrocyte differentiation and glycolysis via the Hippo signaling pathway. The present study demonstrated that SETD7 was a potential molecular target that maintained the chondrocyte phenotype during cartilage tissue engineering and cartilage-associated disease.

show abstract

Section: Discussionmentioning

confidence: 85%